Aelix Therapeutics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $6.46M

  • Investors
  • 6

Aelix Therapeutics General Information

Description

Operator of a therapeutic vaccine biotechnology company intended to cure HIV infection. The company's vaccine is based on an observation of a T-cell immunogen that can elicit a strong broad and focused response against HIV and has the potential to radically transform the treatment of HIV infection, enabling patients to get cured of rare diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Parc Científic de Barcelona
  • Carrer Baldiri Reixac 4-8
  • 08028 Barcelona
  • Spain
+34 934
Primary Industry
Drug Discovery
Other Industries
Therapeutic Devices
Biotechnology
Vertical(s)
Corporate Office
  • Parc Científic de Barcelona
  • Carrer Baldiri Reixac 4-8
  • 08028 Barcelona
  • Spain
+34 934

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aelix Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 12-Jun-2018 $6.46M Completed Generating Revenue
4. Early Stage VC 23-Nov-2017 Completed Generating Revenue
3. Grant 01-Jan-2017 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2017 $52.6K $4.42M Completed Generating Revenue
1. Early Stage VC (Series A) 11-Jan-2016 $4.36M $4.36M Completed Generating Revenue
To view Aelix Therapeutics’s complete valuation and funding history, request access »

Aelix Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary Shares
Ordinary Shares
To view Aelix Therapeutics’s complete cap table history, request access »

Aelix Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a therapeutic vaccine biotechnology company intended to cure HIV infection. The company's vaccine is based o
Drug Discovery
Barcelona, Spain
5 As of 2024

Rockville, MD
 

Vancouver, WA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aelix Therapeutics Competitors (31)

One of Aelix Therapeutics’s 31 competitors is Viriom, a Venture Capital-Backed company based in Rockville, MD.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Viriom Venture Capital-Backed Rockville, MD
Cytodyn Formerly Angel backed Vancouver, WA
Mironid Venture Capital-Backed Newhouse, United Kingdom
GeoVax Labs Corporation Smyrna, GA
Kite Pharma Formerly VC-backed Santa Monica, CA
You’re viewing 5 of 31 competitors. Get the full list »

Aelix Therapeutics Patents

Aelix Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020384323-A1 Dosage regimens for vaccines Pending 14-Nov-2019
CA-3161633-A1 Dosage regimens for vaccines Pending 14-Nov-2019
EP-4058058-A1 Dosage regimens for vaccines Pending 14-Nov-2019
US-11666651-B2 Prime/boost immunization regimen against hiv-1 utilizing a multiepitope t cell immunogen comprising gag, pol, vif, and nef epitopes Active 14-Nov-2019
US-20210145961-A1 Dosage regimens for vaccines Active 14-Nov-2019 A61K39/21
To view Aelix Therapeutics’s complete patent history, request access »

Aelix Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aelix Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
EIT Health Accelerator/Incubator
INNVIERTE SICC Government
Caixa Capital Risc Venture Capital Minority
Criteria Bio Ventures Venture Capital Minority
Johnson & Johnson Innovation - JJDC Corporate Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Aelix Therapeutics FAQs

  • When was Aelix Therapeutics founded?

    Aelix Therapeutics was founded in 2015.

  • Where is Aelix Therapeutics headquartered?

    Aelix Therapeutics is headquartered in Barcelona, Spain.

  • What is the size of Aelix Therapeutics?

    Aelix Therapeutics has 5 total employees.

  • What industry is Aelix Therapeutics in?

    Aelix Therapeutics’s primary industry is Drug Discovery.

  • Is Aelix Therapeutics a private or public company?

    Aelix Therapeutics is a Private company.

  • What is the current valuation of Aelix Therapeutics?

    The current valuation of Aelix Therapeutics is .

  • What is Aelix Therapeutics’s current revenue?

    The current revenue for Aelix Therapeutics is .

  • How much funding has Aelix Therapeutics raised over time?

    Aelix Therapeutics has raised $13.2M.

  • Who are Aelix Therapeutics’s investors?

    EIT Health, INNVIERTE SICC, Caixa Capital Risc, Criteria Bio Ventures, and Johnson & Johnson Innovation - JJDC are 5 of 6 investors who have invested in Aelix Therapeutics.

  • Who are Aelix Therapeutics’s competitors?

    Viriom, Cytodyn, Mironid, GeoVax Labs, and Kite Pharma are some of the 31 competitors of Aelix Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »